Still craving sugar on semaglutide? Here's what's actually happening

The decision you're really facing: ignore it, manage it yourself, or get advice?

When a sugar craving hits during treatment, most people face the same fork in the road. You can try to push through it, you can reach for something sweet and feel frustrated later, or you can try to understand what's actually causing it. That third option is usually the most useful, because the cause shapes the fix.

Semaglutide works as a GLP-1 receptor agonist, mimicking a gut hormone that signals fullness and slows gastric emptying. It also acts on reward circuits in the brain that process food motivation. For many people this blunts cravings broadly, including for sweet foods. But the response is not uniform. Some people find that while their overall appetite falls, their draw toward specific foods (particularly sugary or high-carbohydrate ones) persists or even sharpens in the early weeks of treatment. This is not a sign the medicine isn't working. It's a sign that food reward and appetite are separate systems, and semaglutide doesn't always settle both at the same pace.

There's also a practical layer. When total food intake drops quickly, it's easy to eat less protein and fibre without realising. Both of those nutrients help stabilise blood glucose and keep you feeling satisfied between meals. Without them, blood sugar can dip more noticeably, and the body's fastest solution to a blood sugar dip is a craving for something sweet. The craving in that case isn't really about the medicine, it's about what the reduced eating pattern has created.

How blood sugar shifts on semaglutide can feed the cycle

One of the things semaglutide does is slow the rate at which food leaves the stomach. That means glucose enters the bloodstream more gradually after eating, which is generally beneficial, especially for people with blood sugar regulation issues. But it also means that if meals are small, infrequent or low in sustaining nutrients, the gaps between glucose availability can become more pronounced.

The result for some people is a mild reactive pattern: eat a small amount, blood glucose peaks modestly, then falls, and the craving for something quick-release kicks in. You can read more about how semaglutide interacts with blood sugar and why that matters day-to-day. The NHS notes that common side effects of semaglutide include nausea, constipation and fatigue, all of which can disrupt eating patterns and compound the glucose instability described above, the NHS medicines page for semaglutide covers these in detail.

Hydration matters here too. Thirst and mild dehydration are routinely misread as hunger or sugar cravings. Semaglutide-related nausea can reduce fluid intake without people noticing. Drinking water regularly across the day, particularly before meals, is one of the simplest things to address first, and it costs nothing to try while you work out whether the craving has a deeper cause.

Practical factors that make a real difference

The clinical picture around cravings during Wegovy treatment points to a few consistent patterns. People who maintain reasonable protein intake (around 25–30g per meal as a rough reference, not a target) tend to report fewer and less intense sweet cravings. Fibre from vegetables, legumes and wholegrains slows glucose absorption and extends the feeling of fullness. Neither of these is complicated, but both become harder to achieve when overall appetite is suppressed and meals shrink.

Sleep also deserves a mention. Poor or disrupted sleep raises ghrelin (a hunger hormone) and reduces leptin (a satiety hormone), a combination that specifically amplifies cravings for calorie-dense and sweet foods. If you're sleeping badly alongside your treatment, that may be doing more work on the cravings front than the medicine is.

For a broader picture of what to expect with Wegovy as a treatment, including how appetite changes tend to evolve over time, our treatment overview sets out the evidence clearly. And if you're thinking about what treatment might cost in the context of everything it includes, the Wegovy price page covers that in plain terms.

When to raise this with your prescriber

A mild, occasional sweet craving during the first few weeks of treatment is common and usually settles. The moments where it's worth a proper conversation are when the cravings feel intense enough to undermine your progress, when they're accompanied by dizziness or shakiness (which would warrant prompt clinical review), or when they've persisted well beyond your initial dose adjustment period.

Your prescriber can look at whether a dose timing change, a slower titration, or specific dietary adjustments would help. Some people also find that the pattern shifts again after a dose increase, which is worth knowing in advance rather than being surprised by. Our clinical team reviews every patient individually, not by template, and that review includes exactly this kind of nuance. If you'd like to talk through what you're experiencing, our support team is available seven days a week.

The question of whether semaglutide itself causes sugar cravings or whether the cravings are a downstream effect of changed eating patterns is one our prescribers explore regularly. Usually the answer involves both, and both are manageable. If you haven't yet started treatment and are weighing up your options, a free consultation is the place to begin.